Blood cancer is the generic term for malignant diseases of the bone marrow or blood-forming system, in which normal blood formation is disturbed by the uncontrolled multiplication of malignant blood cells. Because of these cancer cells, the blood can no longer perform its vital tasks, such as fighting infections, transporting oxygen or stopping bleeding.
Curing blood cancer
Blood cancer patients can often only overcome the disease with the help of a stem cell donation from a suitable donor. In the case of leukaemia and malignant lymphomas, the transfer of healthy stem cells is even the only chance of a cure.
Leukaemia
A series of malignant diseases in which there is a pathologically increased proliferation of immature and therefore non-functional white blood cells. Malignant lymphomas are divided into Hodgkin's disease (lymphogranulomatosis) and non-Hodgkin's lymphomas (lymphatic leukaemia) according to their different characteristics.
Lymphoma, malignant
Malignant alteration of lymphatic tissue with swelling of the lymph nodes and pathological enlargement of the spleen. Malignant lymphomas are divided according to their different characteristics into Hodgkin's disease (lymphogranulomatosis) and non-Hodgkin's lymphomas (lymphatic leukemia), which originate from the lymph nodes.
The body reproduces the stem cells within about two weeks. The procedure is comparable to a blood platelet donation and does not lead to a permanent loss of stem cells.
As the world’s largest network of blood stem cell donor centres, DKMS Foundation India has a special responsibility to protect the personal and especially sensitive medical data that registered donors entrust to us. We take data privacy very seriously. It goes without saying that we fully comply with the statutory requirements of the EU’s General Data Protection Regulation (GDPR), but we have also committed to an even higher level of data privacy.